CRTDW yields 400000.00% · PFE yields 6.13%● Live data
📍 CRTDW pulled ahead of the other in Year 1
Combined, CRTDW + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CRTDW + PFE for your $10,000?
Creatd, Inc., a technology company, provides economic opportunities for creators in the United States. It operates in four segments: Creatd Labs, Creatd Partners, Creatd Ventures, and Creatd Studios. The company's flagship product is Vocal that delivers a digital publishing platform organized into niche-communities capable of hosting various rich media content. Its Vocal platform enhances the visibility of content and maximizes viewership; and provides advertisers access to target markets that closely match its interests. The company also offers Vocal for Brands, a content marketing that fosters relationships between brands and creators through its suite of agency services; Seller's Choice, performance marketing initiatives; and WHE Agency, an influencer marketing. In addition, it builds, develops, and scales e-commerce brands, such as Camp and Dune Glow Remedy. Further, the company's Creatd studios elevates creators to develop their content for television, film, prints, and podcasts. It serves businesses and consumers. The company was formerly known as Jerrick Media Holdings, Inc. and changed its name to Creatd Inc. in September 2020. Creatd, Inc. is headquartered in New York, New York.
Full CRTDW Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.